MARIA ACEVEDO: Open Payments
NPI 1992363535 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,884 in 173 payments from 20 companies in 2025. Trend: 2023 $3,064 · 2024 $2,005 · 2025 $3,884
Food & beverage: $3,884
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 17 | $573 |
| Otsuka America Pharmaceutical, Inc. | 27 | $562 |
| Vanda Pharmaceuticals Inc. | 15 | $401 |
| ABBVIE INC. | 22 | $355 |
| Neurocrine BioSciences, Inc. | 12 | $335 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $308 |
| E.R. Squibb & Sons, L.L.C. | 13 | $266 |
| Teva Pharmaceuticals USA, Inc. | 13 | $243 |
| Lundbeck LLC | 10 | $209 |
| Alkermes, Inc. | 7 | $137 |
Products named: REXULTI, VRAYLAR, INGREZZA, FANAPT, INVEGA SUSTENNA, CAPLYTA, COBENFY, SPRAVATO.
Industry payments across CA — which companies pay providers there.
